Skip to main content
Log in

Extreme Clinical Variability of Dilated Cardiomyopathy in Two Siblings With Alström Syndrome

  • Case Report
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Alström syndrome (ALMS) is a rare autosomal recessive disorder caused by mutations in the ALMS1 gene. We report two brothers, 3 and 4 years of age and diagnosed with ALMS, who initially presented in infancy with severe dilated cardiomyopathy during febrile respiratory infection. The disease course in the two siblings was marked by significant intrafamilial variability. Although cardiomyopathy in the older sibling has mainly resolved thus allowing for the discontinuation of medical therapy, heart function in the younger sibling continues to deteriorate despite maximal drug support with furosemide, carvedilol, captopril, and aldospirone. Genetic analysis revealed homozygous mutations, c.8008C>T (R2670X), in ALMS1 resulting in premature protein truncation. This report further emphasizes the exceptional intrafamilial variability of ALMS, mainly during the natural course of cardiac disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bond J, Flintoff K, Higgins J et al (2005) The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy. J Med Genet 42:e10

    Article  PubMed  CAS  Google Scholar 

  2. Collin GB, Marshall JD, Ikeda A et al (2002) Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat Genet 31:74–78

    PubMed  CAS  Google Scholar 

  3. Foerster SR, Canter CE, Cinar A et al (2010) Ventricular survival and survival are more favorable for myocarditis than for idiopathic dilated remodeling and cardiomyopathy in childhood: an outcomes study from the pediatric cardiomyopathy Registry. Circulation 3:689–697

    PubMed  Google Scholar 

  4. Girard D, Petrovsky N (2011) Alström syndrome: insights into the pathogenesis of metabolic disorders. Nat Rev Endocrinol 7:77–88

    Article  PubMed  CAS  Google Scholar 

  5. Hearn T, Spalluto C, Phillips VJ et al (2005) Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes 54:1581–1587

    Article  PubMed  CAS  Google Scholar 

  6. Hoffman JD, Jacobson Z, Young TL et al (2005) Familial variable expression of dilated cardiomyopathy in Alström syndrome: a report of four sibs. Am J Med Genet A 135:96–98

    PubMed  CAS  Google Scholar 

  7. Loudon MA, Bellenger NG, Carey CM et al (2009) Cardiac magnetic resonance imaging in Alström syndrome. Orphanet J Rare Dis 4:14

    Article  PubMed  Google Scholar 

  8. Makaryus AN, Zubrow ME, Marshall JD et al (2007) Cardiac manifestations of Alström syndrome: echocardiographic findings. J Am Soc Echocardiogr 20:1359–1363

    Article  PubMed  Google Scholar 

  9. Marshall JD, Bronson RT, Collin GB et al (2005) New Alström syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med 165:675–683

    Article  PubMed  Google Scholar 

  10. Marshall JD, Beck S, Maffei P et al (2007) Alström syndrome. Eur J Hum Genet 15:1193–1202

    Article  PubMed  CAS  Google Scholar 

  11. Minton JA, Owen KR, Ricketts CJ et al (2006) Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome. J Clin Endocrinol Metab 91:3110–3116

    Article  PubMed  CAS  Google Scholar 

  12. Pereiro I, Hoskins BE, Marshall JD et al (2011) Arrayed Primer Extension (APEX) technology simplifies mutation detection in Bardet Biedl and Alström Syndrome. Eur J Hum Genet 19:485–488

    Article  PubMed  Google Scholar 

  13. Towbin JA, Lowe AM, Colan SD et al (2006) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296:1867–1876

    Article  PubMed  CAS  Google Scholar 

  14. Zulato E, Favaretto F, Veronese C et al (2011) ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis. PLoS One 6:e19081

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the patients and their families for their participation in this study. J. D. M., G. B. C, and J. K. N. were supported by a grant from the National Institutes of Health Grant No. HD036878. We are grateful to Alström Syndrome International and Alström Syndrome Canada for support for the Asper Ophthalmics microarray evaluation. The Jackson Laboratory institutional allele typing and sequencing shared services were supported by the United States Public Health Service, National Institutes of Health (Grant No. CA034196).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ronen Spiegel.

Additional information

Jamal Mahamid and Avraham Lorber contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mahamid, J., Lorber, A., Horovitz, Y. et al. Extreme Clinical Variability of Dilated Cardiomyopathy in Two Siblings With Alström Syndrome. Pediatr Cardiol 34, 455–458 (2013). https://doi.org/10.1007/s00246-012-0296-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-012-0296-6

Keywords

Navigation